Why it matters: The launch of Indias generic semaglutide signals global GLP-1 pricing and competition, especially as Novos semaglutide also faces patent losses in Canada, China and Brazil
Tirzepatide is a glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist approved for type 2 diabetes management (Mounjaro) and chronic weight management (Zepbound)
Thirdparty testing, batch certificates, and transparent ingredient lists help you pick a product aligned with the doses used in trials
If you are unsure about how to store your medication correctly, consult your GP, practice nurse, or community pharmacist for guidance
Gastroparesis: Use with extreme caution or avoid both slow gastric emptying
And unlike many past weight loss drugs, GLP-1s are backed by solid research making them feel like a game changer for people who've struggled despite doing "everything right." In this story But as with most things in health and wellness, the full story is more complicated
